HES5 and pulmonary arterial hypertension: Inhibition of the expression of HES-5, by HES5 siRNA, significantly reduced proliferation and 3[H]leucine incorporation in PAH sPASMCs, indicating that NOTCH3 signaling through HES-5 promotes pulmonary arterial medial hyperplasia [8].